Innovations span diagnostics and treatment modalities, including AI-powered rapid viral detection via nanopore technology, promising faster clinical decisions. Linear Diagnostics secured £1M UK funding for an isothermal nucleic acid amplification platform targeting STIs, optimizing near-patient testing. In neurology, base editors delivered via Dual SORT LNPs demonstrated correction of mutations in alpha-1 antitrypsin deficiency across liver and lung, evidencing multi-organ gene editing applicability. These breakthroughs enhance diagnostic precision and therapeutic options in infectious and genetic diseases.